We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01013831
First Posted: November 16, 2009
Last Update Posted: February 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)